Assembly Biosciences (ASMB) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual meeting scheduled for June 4, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 3, 2026.
Voting matters and shareholder proposals
Election of nine directors is proposed, with all nominees recommended by the board.
Advisory vote on executive compensation (say-on-pay) is included.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to amend the 2018 Stock Incentive Plan to increase shares reserved by 1,200,000.
Proposal to amend the 2018 Employee Stock Purchase Plan to increase authorized shares to 515,000.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Assembly Biosciences
- Long-acting antivirals for herpes and hepatitis advance with strong efficacy, safety, and Gilead partnership.ASMB
Corporate presentation8 May 2026 - Gilead exercised its HPI option, $35M paid, $9.1M net loss, and strong cash reserves maintained.ASMB
Q1 20267 May 2026 - Board recommends approval of all annual meeting proposals, including equity plan amendments.ASMB
Proxy filing23 Apr 2026 - Biotech firm launches $100M at-the-market stock offering to fund antiviral pipeline and operations.ASMB
Registration filing19 Mar 2026 - 2025 revenue jumped to $72.3M, net loss shrank to $6.1M, and cash reserves rose to $248.1M.ASMB
Q4 202519 Mar 2026 - Shelf registration allows up to $250M in securities to fund antiviral R&D and operations.ASMB
Registration Filing16 Dec 2025 - Gilead is reselling 6.98M shares, with no proceeds to the issuer, amid deep R&D collaboration.ASMB
Registration Filing16 Dec 2025 - Up to 98% HSV-2 shedding reduction and strong safety seen in Phase 1b for two novel therapies.ASMB
Study Result9 Dec 2025 - Shareholders will vote on director elections, compensation, auditor, and equity plan amendments.ASMB
Proxy Filing2 Dec 2025